期刊文献+

多索茶碱注射液与注射用氟氯西林钠两种药物配伍稳定性的实验研究 被引量:1

Research on Compatible Stability of Doxofylline Injection and Flucloxacillin Sodium
下载PDF
导出
摘要 目的探讨多索茶碱注射液与注射用氟氯西林钠分别在0.9%氯化钠注射液和5%葡萄糖注射液中配伍的稳定性。方法于室温(25℃)条件下,分别观察及测定8h内配伍液的外观、pH值,并用高效液相色谱法测定配伍液中两种药物成分的含量,计算回收率并判明二者的线性关系。结果两药配伍后8h内,除在5h时点的5%葡萄糖注射液中检测到多索茶碱的含量有降低外,其余外观、pH值、含量、回收率等均无明显变化,两药检测浓度均呈良好线性关系。结论多索茶碱注射液与注射用氟氯西林钠可于常温下在0.9%氯化钠注射液和5%葡萄糖注射液中配伍使用,但在5%葡萄糖注射液中配伍时宜于4h内完成滴注。 OBJECTIVE To study the compatible stability of doxofylline injection and flucloxacillin sodium in the Sodium Chloride Injection( 0. 9%) and Glucose Injection( 5%) respectively. METHODS The appearance of the liquid was observed and its pH value was measured,content of two kinds of mixture of drug components was determined with high performance liquid chromatography at the room temperature( 25℃) conditions in 8hours. RESULTS In addition to the content of doxofylline in the 5% Glucose Injection was decreased in 5h,the appearance,pH value and content had no obvious change with 8h after two medicines compatibility. CONCLUSION Doxofylline Injection and flucloxacillin sodium for injection can be compability in the 0. 9% Sodium Chloride Injection and 5% Glucose Injection at room temperature,but the infusion of compatibility in 5% Glucose Injection should be completed in 4h.
作者 肖燕
出处 《海峡药学》 2014年第6期19-21,共3页 Strait Pharmaceutical Journal
关键词 多索茶碱注射液 注射用氟氯西林钠注射液 配伍 稳定性 高效液相色谱法 Doxofylline injection Flucloxacillin Sodium injection Compatibility Stability HPLC
  • 相关文献

参考文献3

二级参考文献11

  • 1郭辉,徐小莹,何丽一,黄俊华.多索茶碱在大鼠体内的药代动力学[J].药学学报,1997,32(2):81-84. 被引量:7
  • 2 Franzone JS,Cirillo R, Biffignandi P. Doxofylline exerts a prophylactic effect againstbronchocostriction and pleurisy induced by PAF[J]. Eur J Pharmacol, 1989, 165(2)∶269
  • 3 Grossi E, Franzone JS, Biffignandi P,et al. Effect of doxofylline, a novelbronchodilator, and theophylline in reversible COPD patients[J]. J Clin Pharm Ther,1988, 45∶168 [3] Lagana A, Bizzarri M, Marino A,et al. Soild phase extration and highperformance liquid chromatographic determination of doxophylline in plasma[J]. BiomedChromatogr, 1990, 4(5)∶205
  • 4 Bolona E,Lagana A,Terracino D,et al. Oral and intravenous pharmacokineticprofiles of doxofylline in patients with chronic bronchitis[J]. J Int MedRes,1990,18(4)∶282
  • 5 Franzone JS, Cravanzola C, Masera F. Preliminary studies of theabsorption,distribution and excretion of 2-(7'-thephyllinoemethyl)-1,3-dioxolane in rat[J].Farmaco Sci, 1981, 36 (3)∶220
  • 6 Stavaric B. Methylxanthines: toxicity to humans. 1: Theophylline[J]. JChem Toxicol, 1988, 26∶541
  • 7 加藤隆一,钅 兼 哲也编.药物代谢学[M].第3版.东京:东京化学同人,1997.51~61
  • 8 Viillani F, De Maria P, Ronchi E, et al. Oral doxophylline in patients withchronic obstructive pulmonary disease[J]. Int J Clin Pharmacol Ther Toxicol, 1997, 35(3)∶107
  • 9 Grosa G, Franzone JS,Biglino G. Metabolism of doxofylline by rat livermicrosomes[J]. Am Sci Pharmacol & Exp Ther,1986,14 (2)∶33 (收稿:2000-01-14  修回:2000-03-01)
  • 10蓝红,姜素椿.氟氯西林胶囊剂口服的疗效及安全性临床评价[J].中国抗生素杂志,1999,24(5):350-352. 被引量:10

共引文献83

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部